Inhibition of PARP1 enhances sensitivity to radiation in various tumor types including those of lung, ovary, and prostate; PARP inhibition in conjunction with radiation treatment could be effective in these cancers [20, 23, 24]. This evidence concerns the gene PARP1 and cancer.